Patents by Inventor Anna Bunin

Anna Bunin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240051966
    Abstract: Among other things, the present disclosure provides compounds, compositions thereof, and methods of using the same. In some embodiments, compounds of the present disclosure bind to Fc receptors, e.g., CD16a. In some embodiments, compounds of the present disclosure are useful for treating various conditions, disorders or diseases including cancer.
    Type: Application
    Filed: November 18, 2022
    Publication date: February 15, 2024
    Inventors: Anna BUNIN, Lawrence G. IBEN, Douglas MANION, David Adam SPIEGEL, Matthew Ernest WELSCH
  • Publication number: 20230128688
    Abstract: Among other things, the present disclosure provides technologies for site-directed conjugation of various moieties of interest to target agents. In some embodiments, the present disclosure utilizes target binding moieties to provide high conjugation efficiency and selectivity. In some embodiments, provided technologies are useful for preparing antibody conjugates.
    Type: Application
    Filed: November 18, 2020
    Publication date: April 27, 2023
    Inventors: Luca RASTELLI, David Adam SPIEGEL, Matthew Ernest WELSCH, Tetyana BERBASOVA, Michael C. CUKAN, Lawrence Gerald IBEN, Ada Margaret VAILL, Anna BUNIN, Christian Marcel VIDAL, Enrique ALVAREZ
  • Patent number: 11572370
    Abstract: Among other things, the present disclosure provides compounds, compositions thereof, and methods of using the same. In some embodiments, compounds of the present disclosure bind to Fc receptors, e.g., CD16a. In some embodiments, compounds of the present disclosure are useful for treating various conditions, disorders or diseases including cancer.
    Type: Grant
    Filed: January 8, 2019
    Date of Patent: February 7, 2023
    Assignee: BIOHAVEN THERAPEUTICS LTD.
    Inventors: Anna Bunin, Lawrence G. Iben, Douglas Manion, David Adam Spiegel, Matthew Ernest Welsch
  • Publication number: 20230028880
    Abstract: Among other things, the present disclosure provides compounds comprising antibody binding moieties and CD38-binding targeting moieties. In some embodiments, provided compounds recruit various types of antibodies to diseased cells such as cancer cells, and induce immune activities to kill such cells. Provided technologies are useful for treating various diseases including cancer.
    Type: Application
    Filed: June 24, 2020
    Publication date: January 26, 2023
    Inventors: Luca RASTELLI, Matthew Ernest WELSCH, Anna BUNIN, Ann Marie K. ROSSI, Tetyana BERBASOVA
  • Publication number: 20220356191
    Abstract: Among other things, the present disclosure provides compounds, compositions thereof, and methods of using the same. In some embodiments, compounds of the present disclosure bind to Fc receptors, e.g., CD16a. In some embodiments, compounds of the present disclosure are useful for treating various conditions, disorders or diseases including cancer.
    Type: Application
    Filed: January 8, 2019
    Publication date: November 10, 2022
    Inventors: Anna Bunin, Lawrence G. Iben, Douglas Manion, David Adam Spiegel, Matthew Ernest Welsch
  • Publication number: 20220040231
    Abstract: Among other things, the present disclosure provides technologies comprising immune cells and antibody-recruiting molecules. In some embodiments, immune cells are memory-like natural killer cells. In some embodiments, provided technologies are particularly useful for treating a condition, disorder or disease like cancer. In some embodiments, provided technologies provide high efficacy. In some embodiments, provided technologies provide less or less severe side effects associated with natural killer cell therapy.
    Type: Application
    Filed: December 20, 2019
    Publication date: February 10, 2022
    Inventors: Luca Rastelli, Anna Bunin